Aliases & Classifications for Dysphagia

MalaCards integrated aliases for Dysphagia:

Name: Dysphagia 51 29 52
Deglutition Disorders 69

Classifications:



External Ids:

ICD10 33 R13

Summaries for Dysphagia

NINDS : 51 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Dysphagia, also known as deglutition disorders, is related to extrapontine myelinolysis and myopathy, areflexia, respiratory distress, and dysphagia, early-onset, and has symptoms including abdominal pain, constipation and diarrhea. An important gene associated with Dysphagia is MEGF10 (Multiple EGF Like Domains 10). The drugs Cetuximab and Fluorouracil have been mentioned in the context of this disorder. Affiliated tissues include testes, lung and tongue.

Wikipedia : 72 Dysphagia is the medical term for the symptom of difficulty in swallowing. Although classified under... more...

Related Diseases for Dysphagia

Diseases related to Dysphagia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 310)
id Related Disease Score Top Affiliating Genes
1 extrapontine myelinolysis 26.8 MEGF10 MT-ND3 MT-ND5 NARS2 PABPN1 PIK3C2A
2 myopathy, areflexia, respiratory distress, and dysphagia, early-onset 12.2
3 odontoma-dysphagia syndrome 12.1
4 dysphagia lusoria 12.1
5 plummer vinson syndrome 11.7
6 oculopharyngeal muscular dystrophy 11.2
7 swallowing disorders 11.1
8 opitz-gbbb syndrome 11.0
9 aspiration pneumonia 11.0
10 esophageal tuberculosis 10.9
11 aberrant subclavian artery 10.9
12 myasthenia gravis 10.9
13 central pontine myelinolysis 10.8
14 opitz gbbb syndrome, type ii 10.8
15 chromosome 1p36 deletion syndrome 10.7
16 thiamine metabolism dysfunction syndrome 2 10.7
17 neurodegeneration with brain iron accumulation 3 10.7
18 striatonigral degeneration, infantile 10.7
19 chronic progressive external ophthalmoplegia 10.7
20 paraganglioma and gastric stromal sarcoma 10.6
21 spastic paralysis, infantile onset ascending 10.6
22 leigh syndrome 10.6
23 scapuloperoneal syndrome, neurogenic, kaeser type 10.6
24 spinocerebellar ataxia 7 10.6
25 pontocerebellar hypoplasia, type 6 10.6
26 esophagitis, eosinophilic, 1 10.6
27 peroxisome biogenesis disorder 8b 10.6
28 myoclonus, intractable, neonatal 10.6
29 wilson disease 10.6
30 pontocerebellar hypoplasia, type 2e 10.6
31 neurodegeneration with brain iron accumulation 4 10.6
32 dystonia-12 10.6
33 capos syndrome 10.6
34 fazio-londe disease 10.6
35 amyotrophic lateral sclerosis 1 10.6
36 spinal and bulbar muscular atrophy of kennedy 10.6
37 mohr-tranebjaerg syndrome 10.6
38 achalasia, familial esophageal 10.6
39 achalasia-microcephaly syndrome 10.6
40 thyroglossal duct cyst, familial 10.6
41 oculopharyngodistal myopathy 10.6
42 laryngeal tuberculosis 10.6
43 colonic pseudo-obstruction 10.6
44 intestinal pseudo-obstruction 10.6
45 biotin-thiamine-responsive basal ganglia disease 10.6
46 kcnk9 imprinting syndrome 10.6
47 primary familial brain calcification 10.6
48 adolescent-onset dystonia of mixed type 10.6
49 corticobasal degeneration 10.6
50 diffuse cutaneous systemic sclerosis 10.6

Graphical network of the top 20 diseases related to Dysphagia:



Diseases related to Dysphagia

Symptoms & Phenotypes for Dysphagia

UMLS symptoms related to Dysphagia:


abdominal pain, constipation, diarrhea, dyspepsia, flatulence, eructation, and gas pain, headache, heartburn, icterus, nausea, nausea and vomiting, pain, seizures, signs and symptoms, digestive, vomiting, symptoms involving digestive system, other symptoms involving digestive system, odynophagia, pain in esophagus (finding), absent deglutition, swallowing problems, digestive system symptom, choking sensation, gastrointestinal gas, symptom as reason for upper g.i. examination, pseudobulbar signs, dysphagia, pharyngeal phase, dysphagia, pharyngoesophageal phase

Drugs & Therapeutics for Dysphagia

Drugs for Dysphagia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 491)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cetuximab Approved Phase 4,Phase 3,Phase 2,Phase 1 205923-56-4 56842117 2333
2
Fluorouracil Approved Phase 4,Phase 3,Phase 2 51-21-8 3385
3
Sucralfate Approved Phase 4 54182-58-0
4
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3 57808-66-9 3151
5
Dopamine Approved Phase 4,Phase 3 51-61-6, 62-31-7 681
6
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 73590-58-6 4594
7
Alginic acid Approved, Experimental Phase 4,Phase 3,Phase 1 9005-32-7
8
Esomeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 161796-78-7, 119141-88-7 4594 9579578
9
Dexlansoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 138530-94-6, 103577-45-3 9578005
10
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 103577-45-3 3883
11
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
12
Acetylcholine Approved Phase 4,Phase 2 51-84-3 187
13
Rabeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 117976-89-3 5029
14
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1 102625-70-7 4679
15
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3 55-56-1 9552079 2713
16
Menthol Approved Phase 4,Phase 1,Phase 2,Early Phase 1 2216-51-5 16666
17
Remifentanil Approved Phase 4 132875-61-7 60815
18
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3 2180-92-9, 38396-39-3 2474
19
Levobupivacaine Approved Phase 4 27262-47-1 92253
20
Famotidine Approved Phase 4,Phase 2,Phase 3 76824-35-6 3325
21
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 75614-87-8, 51-45-6 774
22
Morphine Approved, Investigational Phase 4 57-27-2 5288826
23
Metoclopramide Approved, Investigational Phase 4,Phase 3 364-62-5 4168
24
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
25
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
26
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
27
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
28
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
29
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
30
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 22916-47-8 4189
31
Nystatin Approved, Vet_approved Phase 4 1400-61-9 11953884
32
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
33
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Phase 3 15307-86-5 3033
34
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 5281106 54677470
35
Magnesium Hydroxide Approved Phase 4,Phase 3,Phase 1 1309-42-8
36
Aluminum hydroxide Approved Phase 4,Phase 3,Phase 1 21645-51-2
37 Magnesium trisilicate Approved Phase 4,Phase 3,Phase 1 14987-04-3
38
Nortriptyline Approved Phase 4,Phase 2,Phase 3 72-69-5 4543
39
Pectin Approved, Vet_approved Phase 4,Phase 3 9000-69-5 441476
40
Ethanol Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 64-17-5 702
41
Cimetidine Approved Phase 4 51481-61-9 2756
42
Nizatidine Approved Phase 4,Phase 3 76963-41-2 3033637
43
Ranitidine Approved Phase 4,Phase 3,Phase 2 66357-59-3, 66357-35-5 3001055
44
Methylprednisolone Approved, Vet_approved Phase 4,Phase 1 83-43-2 6741
45
Prednisolone Approved, Vet_approved Phase 4,Phase 1 50-24-8 5755
46
Benzydamine Approved Phase 4 100-46-9, 642-72-8 7504
47
Trimebutine Approved Phase 4 39133-31-8
48
Prednisone Approved, Vet_approved Phase 4,Phase 1 53-03-2 5865
49
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
50
Asenapine Approved Phase 4 85650-56-2, 65576-45-6 3001386

Interventional clinical trials:

(show top 50) (show all 1254)

id Name Status NCT ID Phase Drugs
1 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
2 Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Unknown status NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
3 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
4 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4 omeprazole+domperidone SR;omeprazole
5 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
6 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Unknown status NCT01503476 Phase 4
7 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
8 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4 sodium alginate;esomeprazole
9 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4 dexlansoprazole
10 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
11 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
12 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
13 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
14 Repetitive Transcranial Stimulation (rTMS) in Post Stroke Dysphagia Completed NCT01081444 Phase 4
15 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
16 Dysphagia in Elderly Medical Patients Completed NCT01006330 Phase 4
17 Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
18 Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain Completed NCT02322346 Phase 4 Group LL;Group HL
19 Acetaminophen's Efficacy For Post-operative Pain Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
20 Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia Completed NCT00528541 Phase 4
21 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4 Omeprazole;Famotidine
22 Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers Completed NCT01924234 Phase 4 Morphine;Remifentanil
23 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients Completed NCT02189954 Phase 4
24 Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial Completed NCT01906060 Phase 4
25 Opioid Effects on Swallowing and Esophageal Sphincter Pressure Completed NCT01191645 Phase 4 naloxone;remifentanil;Sodium Chloride;metoclopramide
26 Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope Completed NCT01271543 Phase 4
27 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) Completed NCT00872755 Phase 4
28 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4 Tacrolimus/Clotrimazole Troche;Tacrolimus/Nystatin Suspension
29 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Completed NCT00641602 Phase 4 Esomeprazole;Lansoprazole
30 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00242736 Phase 4 Esomeprazole
31 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis Completed NCT02229747 Phase 4 Meloxicam;Diclofenac;Nimesulide
32 The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series Completed NCT02106273 Phase 4
33 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed NCT01135368 Phase 4 Lansoprazole
34 Esophageal Fully Covered Metal Stents in Caustic Strictures Study Completed NCT01899300 Phase 4
35 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
36 A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study Completed NCT02049112 Phase 4
37 Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B Completed NCT03128736 Phase 4 Esomeprazole group;Dexlansoprazole group
38 The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity Completed NCT02958046 Phase 4 Lansoprazole/Domperidone
39 The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity Completed NCT02689999 Phase 4 Dexrabeprazole 10 mg Enteric-Coated Tablets
40 Role of Pepsin Assay in Wheezy Infants Completed NCT02685436 Phase 4 Omeprazole and domperidone
41 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Completed NCT02351960 Phase 4 Dexlansoprazole
42 Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease. Completed NCT01601379 Phase 4
43 Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea Completed NCT01018160 Phase 4 Rabeprazole Sodium
44 A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) Completed NCT00734097 Phase 4 Esomeprazole 40 mg
45 Role of Mosapride in Patients With Gastroesophageal Reflux Disease Completed NCT00729339 Phase 4 mosapride for the first month and placebo for the 2nd month;placebo for the first and mosapride for the second month
46 Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US Completed NCT00660660 Phase 4 Esomeprazole;Placebo
47 Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously Completed NCT00635414 Phase 4 Esomeprazole;Esomeprazole
48 An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Dise Completed NCT00629564 Phase 4 Esomeprazole;Esomeprazole
49 Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv Completed NCT00626262 Phase 4 Esomeprazole
50 Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00625495 Phase 4 Esomeprazole;Esomeprazole

Search NIH Clinical Center for Dysphagia

Genetic Tests for Dysphagia

Genetic tests related to Dysphagia:

id Genetic test Affiliating Genes
1 Dysphagia 29

Anatomical Context for Dysphagia

MalaCards organs/tissues related to Dysphagia:

39
Testes, Lung, Tongue, Brain, Bone, Thyroid, Colon

Publications for Dysphagia

Articles related to Dysphagia:

(show top 50) (show all 1068)
id Title Authors Year
1
Dysphagia lusoria as a differential diagnosis in intermittent dysphagia. ( 27093895 )
2017
2
A Rare Cause of Dysphagia in Children: Primary Cricopharyngeal Achalasia. ( 28770566 )
2017
3
Diffuse Idiopathic Skeletal Hyperostosis Involving Cervical and Lumbar Spine Presenting with Dysphagia: A Case Report. ( 28819624 )
2017
4
Pulmonary hyalinizing granuloma presenting with dysphagia: a rare presentation. ( 27940652 )
2017
5
Gastrointestinal: Unusual endoscopic finding in a patient with dysphagia and gastro-esophageal reflux. ( 28948705 )
2017
6
Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases. ( 28404653 )
2017
7
Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis. ( 28249651 )
2017
8
Lymphocytic esophagitis: A rare finding in adult patients with dysphagia and food impaction. ( 28089355 )
2017
9
Cervical diffuse idiopathic skeletal hyperostosis (DISH) causing oropharyngeal dysphagia. ( 28314808 )
2017
10
Assessing Dysphagia in Older Adults. ( 28906187 )
2017
11
Dysphagia Due to Kindler Syndrome. ( 28745323 )
2017
12
Cognitive impairment has no impact on hospital-associated dysphagia in aspiration pneumonia patients. ( 28940784 )
2017
13
Predictive factors for oropharyngeal dysphagia after prolonged orotracheal intubation. ( 28951127 )
2017
14
A rare association of dysphagia and cervical compressive myelopathy in diffuse idiopathic skeletal hyperostosis. ( 28084279 )
2017
15
Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports. ( 28944075 )
2017
16
A Survey of Australian Dysphagia Practice Patterns. ( 28932903 )
2017
17
Pearly Esophageal Papules: An Innocent Bystander in the Evaluation of Dysphagia. ( 28911948 )
2017
18
Botulinum toxin alleviates dysphagia of patients with inclusion body myositis. ( 28870555 )
2017
19
Paraneoplastic Dermatomyositis Syndrome Presenting as Dysphagia. ( 28912913 )
2017
20
In this issue - July 2017: RHDV vaccine protects against both strains of virus a88A^a88 Olfactory neuroblastoma in a Malamute a88A^a88 Coincidental conditions affecting dysphagia in a Miniature Poodle a88A^a88 Support for storing high-quality bovine colostrum a88A^a88 Sarcoptic mange in koalas a88A^a88 Renal oxalosis in rare Gilbert's potoroos a88A^a88 Novel trypanosomes in a little red flying fox. ( 28653384 )
2017
21
Giant Thoracic Aortic Aneurysm Manifested as Dysphagia and Dyspnea. ( 28007285 )
2017
22
Mild to Moderate Dysphagia Following Very Low-dose Abobotulinumtoxin A for Platysmal Bands. ( 28915289 )
2017
23
Title: 'Dysphagia: more than meets the eye?' ( 28947351 )
2017
24
European Society for Swallowing Disorders FEES Accreditation Program for Neurogenic and Geriatric Oropharyngeal Dysphagia. ( 28779300 )
2017
25
Effects of Shaker exercise in stroke survivors with orophagyngeal dysphagia. ( 28946582 )
2017
26
The Role of the Corpus Callosum in Pediatric Dysphagia: Preliminary Findings from a Diffusion Tensor Imaging Study in Children with Unilateral Spastic Cerebral Palsy. ( 28597327 )
2017
27
Clinical Profile of Dysphagia in Patients with Parkinson's Disease, Progressive Supranuclear Palsy and Multiple System Atrophy. ( 28799303 )
2017
28
A comparison of the swallowing function and quality of life by oral intake level in stroke patients with dysphagia. ( 28931986 )
2017
29
Systematic review and evidence based recommendations on texture modified foods and thickened liquids for adults (above 17 years) with oropharyngeal dysphagia - An updated clinical guideline. ( 28939270 )
2017
30
Eagle syndrome as an uncommon cause of dysphagia. ( 28533026 )
2017
31
Ability of High-Resolution Manometry to Determine Feeding Method and to Predict Aspiration Pneumonia in Patients With Dysphagia. ( 28374817 )
2017
32
An Unusual Cause of Pediatric Dysphagia: Bronchogenic Cyst. ( 28229098 )
2017
33
Dysphagia in Perry Syndrome: Pharyngeal Pressure in Two Cases. ( 28690533 )
2017
34
Calf circumference is associated with dysphagia in acute-care inpatients. ( 28939287 )
2017
35
A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant. ( 28012096 )
2017
36
Mechanisms underlying reflux symptoms and dysphagia in patients with joint hypermobility syndrome, with and without postural tachycardia syndrome. ( 28191707 )
2017
37
Correlations Between Patient-Reported Dysphagia Screening and Penetration-Aspiration Scores in Head and Neck Cancer Patients Post-oncological Treatment. ( 28887707 )
2017
38
Dysphagia in Friedreich Ataxia. ( 28474131 )
2017
39
Appropriate nutritional management in patients with impaired mastication and those with mild dysphagia: a multicenter study of the usefulness of novel foods processed and softened by enzymes. ( 28917225 )
2017
40
Dysphagia in Rett Syndrome: A Descriptive Study. ( 28766954 )
2017
41
Early Screening Parameters for Dysphagia in Acute Ischemic Stroke. ( 28903096 )
2017
42
"Dysphagia-Related Quality of Life in Oculopharyngeal Muscular Dystrophy: Psychometric Properties of the SWAL-QOL Instrument. ( 28472864 )
2017
43
Hiatus Hernia as a Cause of Dysphagia. ( 28730506 )
2017
44
Anti-transcription Intermediary Factor1I^-antibody-positive Dermatomyositis Complicated by Dysphagia. ( 28943591 )
2017
45
Efficacy of BoNT-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with Lateral Medullary Syndrome: a case study. ( 28264544 )
2017
46
High nutrition risk is associated with higher risk of dysphagia in advanced age adults newly admitted to hospital. ( 28913929 )
2017
47
Clinical characteristics of neurogenic dysphagia in adult patients with Chiari malformation type I. ( 28416844 )
2017
48
Dysphagia from esophageal tuberculosis in a patient with undiagnosed HIV infection. ( 28614889 )
2017
49
Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature. ( 27722170 )
2016
50
Radiation exposure from videofluoroscopic swallow studies in children with a type 1 laryngeal cleft and pharyngeal dysphagia: A retrospective review. ( 27619036 )
2016

Variations for Dysphagia

Expression for Dysphagia

Search GEO for disease gene expression data for Dysphagia.

Pathways for Dysphagia

GO Terms for Dysphagia

Cellular components related to Dysphagia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 respiratory chain GO:0070469 8.96 MT-ND3 MT-ND5
2 mitochondrial respiratory chain complex I GO:0005747 8.62 MT-ND3 MT-ND5

Biological processes related to Dysphagia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 mitochondrial respiratory chain complex I assembly GO:0032981 8.96 MT-ND3 MT-ND5
2 mitochondrial electron transport, NADH to ubiquinone GO:0006120 8.62 MT-ND3 MT-ND5

Molecular functions related to Dysphagia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 NADH dehydrogenase (ubiquinone) activity GO:0008137 8.62 MT-ND3 MT-ND5

Sources for Dysphagia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....